Novel CDKs inhibitors for the treatment of solid tumour by simultaneously regulating the cell cycle and transcription control
A novel series of cyclin-dependent kinases (CDKs) inhibitors, which play critical roles in the cell cycle control and regulation of cell transcription, were synthesised. A systematic study of enzymatic and cellular assays led to the identification of compound X22 with a nanomolar potency against CDK...
Saved in:
Main Authors: | Xin Wang (Author), Kaiyuan Deng (Author), Cheng Wang (Author), Yao Li (Author), Tianqi Wang (Author), Zhi Huang (Author), Yakun Ma (Author), Peiqing Sun (Author), Yi Shi (Author), Shengyong Yang (Author), Yan Fan (Author), Rong Xiang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A highly potent and selective inhibitor Roxyl-WL targeting IDO1 promotes immune response against melanoma
by: Guangwei Xu, et al.
Published: (2018) -
Tumour markers in pediatric solid tumours
by: Singal A, et al.
Published: (2005) -
Simultaneous determination of antibiotics in tap water with automatic solid phase extraction-UHPLC-MS/MS
by: Jin-xin ZANG, et al.
Published: (2023) -
Precocious puberty in pediatric solid tumours
by: Dr. Palle Nikitha, et al.
Published: (2024) -
Solid tumours: Building bridges to CAR‐T success
by: John Maher
Published: (2023)